SCIENTIFIC HUB

Follow the evidence.

SCIENTIFIC LITERATURE · MED

Highly potent and specific GSK-3beta inhibitors that block tau phosphorylation and decrease alpha-synuclein protein expression in a cellular model of Parkinson's disease.

ChemMedChem · 2006-02-01

DOI: 10.1002/cmdc.200500039PMID: 16892358

Check source for accessJournal Article; Research Support, N.I.H., ExtramuralOriginal source ↗

Research overview

Source publication and reading guides

This section identifies the original publication. Follow the source for its authors and journal.

Read the original publication ↗

Scientific assessment

01

Research question

Assess the question within the original study’s scope.

02

Methods & sample

Check the source article for study design and sample details.

03

Key findings

An editorially approved findings summary is not yet published for this record.

04

Limitations

Generalizability, bias and clinical meaning require separate assessment.

Methods, samples and clinical conclusions are not inferred from bibliographic metadata.